Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
101 participants
INTERVENTIONAL
2016-01-01
2020-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Water-based Activity to Enhance Recall in Veterans
NCT04296565
Water-based Activity to Enhance Recovery in Long COVID-19
NCT06142253
A Combined Training Program for Veterans With Amnestic Mild Cognitive Impairment
NCT01962038
Personalized, Augmented Cognitive Training (PACT) for Service Members and Veterans with a History of TBI
NCT04560946
Cognitive Rehabilitation and Brain Activity of Attention Control in TBI
NCT02589509
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
These aims will be tested in a two-phase clinical trial with a single group design: 1) exercise training phase and 2) a cognitive training phase. The exercise training phase consists of a water-based physical exercise program that emphasizes cardiovascular fitness and strength training through a combination of non-weight bearing exercises that include land-based stretching and water-based activities. This 2-year pilot project will include 50 Veterans diagnosed with amnestic MCI age 50-90. The exercise component consists of a six-month water-based exercise program followed by a four-week cognitive training program. For the first two months of the water-based exercise program, Veterans will come to thrice-weekly group sessions at Aquatic Therapy Center at the VA Palo Alto Health Care System. This will transition to a self-paced exercise program for the remaining four months. After completion of the exercise program, Veterans will begin classroom-based cognitive training at the VA Palo Alto Health Care System (VAPAHCS). The cognitive training is based on an efficacious cognitive program that is structured around two components, pre-training and mnemonic training, both of which have been used successfully in persons with aMCI. Assessments of adherence will be administered throughout treatment and measures of feasibility will be completed post-treatment.
Participants will complete a variety of neuropsychological measures taping into areas of cognition such as attention, executive functioning, and memory. To study possible predictors of treatment response, the investigators will also collect biological (cardiovascular functioning and brain derived neurotrophic factor \[BDNF\] plasma levels) and genetic data (APOE and BDNF genotypes) from these participants. The investigators hope to provide initial evidence of the feasibility of a waterbased exercise training augmentation for cognitive training thus laying the groundwork for full-scale clinical trials targeting the lessening of cognitive impairment in persons with amnestic MCI by non-pharmacological means.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Water based Activity+ Cognitive Training
water-based physical activity + classroom based cognitive training
Water-based Activity + Cognitive Training
This is an 8 month long two phase intervention. The first phase consists of 6 months of thrice weekly pool based physical activity occurring at the Palo Alto VA Health Care System. After completion of the 6 month long water based physical activity, participants transition to a ten session cognitive training program at the Palo Alto VA. The cognitive training classes are approximately two hours in length and will be spread over ten sessions across 4 weeks.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Water-based Activity + Cognitive Training
This is an 8 month long two phase intervention. The first phase consists of 6 months of thrice weekly pool based physical activity occurring at the Palo Alto VA Health Care System. After completion of the 6 month long water based physical activity, participants transition to a ten session cognitive training program at the Palo Alto VA. The cognitive training classes are approximately two hours in length and will be spread over ten sessions across 4 weeks.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* diagnosis of aMCI
* available informant
* at least one musculoskeletal problem
* sufficient visual and auditory acuity to allow neuropsychological testing
* willingness to participate in exercise training +cognitive training program for eight months
* approval of primary provider to participate in an exercise trial
Exclusion Criteria
* Bipolar I
* Schizophrenia
* or Major Depressive Disorder, determined by the Mini International Neuropsychiatric Interview (MINI)
* diagnosis of dementia, Clinical Dementia Rating (CDR) \> 0.5; modified Hachinski score 4; or delirium
* history of neurological disorder, e.g.:
* multiple sclerosis
* seizure disorder
* stroke
* history of transient ischemic attacks, or systemic illness affecting central nervous system (CNS) function, e.g.:
* liver failure
* kidney failure
* congestive heart failure
* systemic cancer
* acute illness or unstable chronic illness e.g., history of severe liver disease
* cirrhosis
* esophageal
* varices
* ascites
* portal hypertension
* hepatic encephalopathy
* current severe cardiac disease, e.g.:
* uncontrolled atrial fibrillation, defined as mean 24 hour heart rate \>85 beats/min, or 24 hour maximal ventricular rate \>150 beats/min
* uncontrolled ventricular arrhythmias, defined as recurrent ventricular tachycardia \> 3 beats in succession, or 24 hour packed cell volume (PVC) count \> 20%; active
* pericarditis or myocarditis
* Class III/IV heart failure and / or ejection fraction \< 20%
* thrombophlebitis
* pulmonary disease with a drop in O2 Sat with exercise to 90% without oxygen
* embolism within past six months
* inability to participate in an exercise stress test or inability to exercise consistently because of orthopedic or musculoskeletal problems
* morbid obesity (BMI \> 39)
* inability to read, verbalize understanding and voluntarily sign the Informed Consent
50 Years
90 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
VA Office of Research and Development
FED
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jennifer Kaci Fairchild, PhD
Role: PRINCIPAL_INVESTIGATOR
VA Palo Alto Health Care System, Palo Alto, CA
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
VA Palo Alto Health Care System, Palo Alto, CA
Palo Alto, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
12I1-RX001884-01A1
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
E1884-P
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.